Military Health System Research Symposium Aug 26-29
Join us at Booth #218!
Mapping Immunity
Mapping Immunity
Serimmune is an immune intelligence company that decodes the breadth and complexity of human antibody response, empowering discovery projects through a universal serology assay that identifies disease-specific epitopes across proteins and entire proteomes.
Introducing Immune Profiling Services
SERA Platform Used to Identify Features of Long COVID
Serimmune Announces Use of Its SERA Platform in Study
Serimmune’s proprietary Serum Epitope Repertoire Analysis (SERA) technology platform was one of the methods used to analyze the biological processes associated with the development and persistence of Long COVID symptoms, such as fatigue, brain fog and malaise.
Broad Serosurveillance Using SERA Technology
Broad Serosurveillance Using SERA Technology
View our webinar walking through the use of SERA in Broad Serosurveillance and its use as a tool for research applications.
What We Do
We offer a discovery service to academia, government and industry through the Serimmune universal serology platform that utilizes bacterial display peptide library technology and next generation sequencing to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases - all in a single assay.
How We Do It
Serimmune’s Serum Epitope Repertoire Analysis (SERA) technology platform applies bacterial display peptide libraries, next-generation sequencing, machine learning and custom bioinformatics to reveal the many diverse antigens stimulating immunity. Through this, we gain a broad view of an individual’s environmental exposures and the unique immune responses to these exposures in disease and health.
Why We Do It
Serimmune has created a technology to map interactions between functional antibody repertoire and human disease. Using our technology, linkages between antibody response to pathogens have been shown in oncology, autoimmune, infectious, neurodegenerative, and other complex diseases.
Immuno-Therapeutics
Vaccines
Target Discovery
Serimmune Biomarker Discovery Service
Learn about Serimmune’s SERA platform which combines large biological libraries, NGS, and custom bioinformatics to unlock the Circulating Antibody Repertoire to achieve hypothesis free serology.
Neutralizing Epitopes
Biomarkers of Response
Events
MHSRS 2024
Aug 26th-29th
Kissimmee, FL
Experience the latest solutions on the market from 100+ leading manufacturers and suppliers, as well as companies on the forefront of technology, that are committed to advancing and improving the unique medical needs of the Warfighter.
Join us at Booth #218!
Come discover the science at the premier forum for ID health professionals of varied backgrounds and collaborate, connect and learn from each other’s expertise for the improvement of patient care and public health.
Join us at Booth #525!
ID Week 2024
Oct 16th-19th
Los Angeles, CA
In the News
Frontiers in Immunology